medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2016, Number 4

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2016; 32 (4)

Physiopathology of priapism in sickle cell anaemia patients

Roque GW

Language: Spanish
References: 43
Page: 438-446
PDF size: 93.80 Kb.


ABSTRACT

Sickle cell anaemia (SCD) is a disorder with a high index of morbidity, affecting the quality of life of these patients. Priapism is a common complication of SCD and it is characterized by a prolonged and persistent erection of the penis lasting more than 4 hours without associated sexual stimulation. The 95 % of priapism crisis in SCD patients are ischemic type. In this paper we review the new molecular mechanisms implicated in the pathogenesis of ischemic priapism and provide the basis for potential future therapies.


REFERENCES

  1. Weatherall D. The inherited disorders of haemoglobin: an increasingly neglected global health burden. Indian J Med Res. 2011 Oct;134:493-7.

  2. Rees DC, Williams TN, Gladwin MT. Sickle cell disease. The Lancet.2010 Dec;376(9757):2018-31.

  3. Labanaris AP, Zugor V, Wagner C, Witt JH. From Priapus to priapism. J Urol. 2012;187(4)Suppl:e421.

  4. Burnett AL. Pathophysiology of priapism: dysregulatory erection physiology thesis. J Urol. 2003 Jul;170(1):26-34.

  5. Hinman F. Priapism: report of cases and a clinical study of the literature with references to its pathogenesis and surgical treatment. Ann Surg. 1914;60:689-716.

  6. Broderick GA. Priapism and sickle cell anemia: diagnosis and non surgical therapy. J Sex Med. 2012 Jan;9(1):88-103.

  7. Olujohungbe AB, Burnett AL. How I manage priapism due to sickle cell disease. Br J Haematol. 2013;160(6):754-65.

  8. Anele UA, Burnett AL. Erectile dysfunction after sickle cell disease-associated priapism: profile and risk factors. J Sex Med.2015 Mar;12(3):713-9.

  9. Miller ST, Rao SP, Dunn EK, Glassberg KI. Priapism in children with sickle cell disease. J Urol. 1995 Aug;154(2 pt2):844-7.

  10. SharpsteenJRJr, Powars D, Johnson C, Rogers ZR, Williams WD, Posch RJ. Multisystem damage associated with tricorporal priapism in sickle cell disease. Am J Med. 1993 Mar;94(3):289-95.

  11. Mantadakis E, Cavender JD, Rogers ZR, Ewalt DH, Buchanan GR. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol. 1999 Nov-Dec;21(6):518-22.

  12. Ramos CE, Park JS, Ritchey ML, Benson GS. High flow priapism associated sickle cell disease. J Urol. 1995 May;153(5):1619-21.

  13. Adeyoju AB, Olujohungbe AB, Morris J, Yardumian A, Bareford D, AkenovaA,et al. Priapism in sickle cell disease; incidence, risk factors, and complications-an international multicenter study. BJU Int. 2002 Dec;90(9):898-902.

  14. Furtado PS, Costa MP, Valladares F, Ribeiro do Prado, Oliveira da Silva L, Lordelo M, et al. The prevalence of priapism in children and adolescents with sickle cell disease in Brazil. Int J Hematol. 2012 Jun;95(6):648-51.

  15. Cherian J, Rao AR, Thwaini A, Kapasi F, Shergill IS,Samman R. Medical and surgical management of priapism. Postgrad Med J. 2006 Feb;82(964):89-94.

  16. Hagebeuk EE, Bijlmer RP, Koelman JH, Poll -The BT. Respiratory disturbances in Rett syndrome: don't forgets to evaluate upper airway obstruction. J Child Neurol. 2012 Jul;27(7):888-92.

  17. Sinkeviciute I, Kroken RA, Johnsen E. Priapism in Antipsychotic Drug Use: A Rare but Important Side Effect. Case Rep Psychiatry. 2012,2012: 496364. doi:10.1155/2012/496364.

  18. Nagathan DS, Pahwa HS, Kumar A, Goel A. Anticoagulant induced priapism progressing to penile gangrene: a devastating complication. BMJ Case Rep. 2012 Nov; 2012. doi:10.1136/bcr-2012-007073.

  19. Diaz G, Yanes R, Bhandari A, Nieder A. High risk of priapism of recreation alintracavernosal drug abusers. J Urol. 2015;193(4)Suppl:e43.

  20. Halls JE, Patel DV, Walkden M, Patel U. Priapism: Pathophysiology and role of the radiologist. Br J Radiol. 2012 Nov;85(1):S79-85.

  21. Gratzke C, Angulo J, Chitaley K, Dai Y, Kim NN, Paick JS,et al. Anatomy, physiology and pathophysiolgy of erectile disfunction. J Sex Med. 2010 Nov;7(1Pt 2):445-75.

  22. Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010 Jan;7(1 Pt 2):476-500.

  23. Lagoda J,Sezen SF, Cabrini MR, Musicki B,Burnett AL. Molecular Analysis of Erection Regulatory Factors in Sickle Cell Disease Associated Priapism in the Human Penis. J Urol 2013;189(2):762-68.

  24. Fukata Y, Amano M, Kaibuchi K. Rho-Rho kinase pathway in smooth muscle contraction and cytoeskeletal reorganization of non-muscle cells. Trends Pharmacol Sci. 2001 Jan;22(1):32-9.

  25. Dai Y, Zhang Y, Phatarpekar P, Mi T, Zhang H, Blackburn MR, et al.Adenosine signaling, priapism and novel therapies. J Sex Med. 2009 Mar;6 (Suppl 3):292:301.

  26. Anele UA, Morrison BF, Burnett AL. Molecular pathophysiology of priapism: Emerging targets. Curr Drugs Targets. 2015;16(5):474-83.

  27. Kovac JR, Mak SK, Garcia MM, Lue TF. Apathophysiology-based approach to the management of early priapism. Asian J Androl. 2013 Jan;15(1):20-6.

  28. Somlyo AP, Somlyo AV. Ca2+ sensitization in erectile function. J Biol Chem. 2002;277:30614-21.

  29. Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL. New insights into the pathophysiology of sickle cell disease- associated priapism. J Sex Med. 2012 Jan;9 (1):79-87.

  30. Ernst R Schwa red. Erectil dysfunction. New York: Oxford University Press; 2013.

  31. Bivalacqua TJ, Ross AE, Strong TD, Gebska MA, Musicki B, Champion HC. Attenuated RhoA/Rho kinase signaling in penis in transgenic sickle cell mice. Urology. 2010 Aug;76(2):510.e7-510.e12.

  32. Zhang Y, Xia Y. Adenosine signalling in normal and sickle erythrocytes and beyond. Microbes Infect. 2012 Aug;14(10):863-73.

  33. Wen J, Grenz A, Zhang Y, Dai Y, Kellems RE, Blackburn MR, et al. A2B adenosine receptor contribute to penile erection via PIK3/AKT signalling cascade-mediated eNOS activation. FASEB J. 2011 Aug;25:2823-30.

  34. Ning C, Qi L, Wen J, Zhang Y, Zhang W, Wang W, et al. Excessive penile norepinephrine levels underlie impaired erectile function in adenosine A 1 receptor deficient mice. J Sex Med. 2012 Oct;9(10):2552-61.

  35. Ning C, Wen J, Zhang Y, Dai Y, Wang W, Zhang W, et al. Excess adenosine A2B receptor signaling contributes to priapism through HIF 1 mediated reduction of PDE5 gene expression. FASEB J. 2014 Jun;28(6):2725-35.

  36. Dai Y, Zhang Y, Phatarpekar P, Mi T, Zhang H, Blackburn MR, et al. Adenosin signaling, priapism and novel therapies. J Sex Med. 2009 Mar;6(Suppl 3):203-301. doi: 10.1111/j.1743-6109.2008.01187.x

  37. Wen J, Jiang X, Dai Y, Zhang Y, Tang Y, Sun H, et al. Adenosine deaminaseenzymetherapy prevents and reverses the heightened cavernosal relaxation in Priapism.J Sex Med. 2010 Sept;7(9):3011-22.

  38. Morrison BF, Burnett AL. Stutteringpriapism: insightsintopathogenesis and management. CurrUrol Rep. 2012 Aug;13(4):268-76.

  39. Fu S, Tar M, Melman T, Davies KP. Opiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells. FASEB J. 2014 Aug;28(8)3633-44.

  40. Kanika ND, Tar M, Tong Y, Kuppam DS, Melman A, Davies KP. Themechanism of opiorphin-induced experimental priapism in ratsinvolvesactivation of thepolyaminesyntheticpathway. Am J PhysiolCellPhysiol. 2009 Oct;297(4):C916-27.

  41. Shamloul R. Thepotential role of the heme oxygenase/carbonmonoxidesystem in male sexual dysfunctions. J Sex Med. 2009 Feb;6(2):324-33.

  42. Jin YC, Gam SC, Jung JH, Hyun JS, Chang KC, Hyun JS. Expression and activity of heme oxygenase-1 in artificiallyinducedlow-flowpriapism in ratpeniletissues. J Sex Med. 2008 Aug;5(8):1876-82.

  43. Kanika ND, Melman A, Davies KP. Experimental priapismisassociatedwithincreasedoxidative stress and activation of proteindegradationpathways in corporal tissue. Int J Impot Res. 2010 Nov- Dec;22(6):363-73.




2020     |     www.medigraphic.com